Cele, Sandile
Jackson, Laurelle
Khoury, David S.
Khan, Khadija
Moyo-Gwete, Thandeka
Tegally, Houriiyah
San, James Emmanuel
Cromer, Deborah
Scheepers, Cathrine
Amoako, Daniel G.
Karim, Farina
Bernstein, Mallory
Lustig, Gila
Archary, Derseree
Smith, Muneerah http://orcid.org/0000-0002-1516-3270
Ganga, Yashica
Jule, Zesuliwe
Reedoy, Kajal
Hwa, Shi-Hsia http://orcid.org/0000-0002-5648-9808
Giandhari, Jennifer
Blackburn, Jonathan M. http://orcid.org/0000-0001-8988-9595
Gosnell, Bernadett I. http://orcid.org/0000-0002-6336-7489
Abdool Karim, Salim S.
Hanekom, Willem
,
Davies, Mary-Ann
Hsiao, Marvin
Martin, Darren
Mlisana, Koleka
Wibmer, Constantinos Kurt
Williamson, Carolyn
York, Denis
,
Harrichandparsad, Rohen
Herbst, Kobus
Jeena, Prakash
Khoza, Thandeka
Kløverpris, Henrik
Leslie, Alasdair
Madansein, Rajhmun
Magula, Nombulelo
Manickchund, Nithendra
Marakalala, Mohlopheni
Mazibuko, Matilda
Moshabela, Mosa
Mthabela, Ntombifuthi
Naidoo, Kogie
Ndhlovu, Zaza
Ndung’u, Thumbi
Ngcobo, Nokuthula
Nyamande, Kennedy
Patel, Vinod
Smit, Theresa
Steyn, Adrie
Wong, Emily
von Gottberg, Anne
Bhiman, Jinal N. http://orcid.org/0000-0001-6354-4003
Lessells, Richard J.
Moosa, Mahomed-Yunus S.
Davenport, Miles P.
de Oliveira, Tulio
Moore, Penny L. http://orcid.org/0000-0001-8719-4028
Sigal, Alex http://orcid.org/0000-0001-8571-2004
Article History
Received: 14 December 2021
Accepted: 23 December 2021
First Online: 23 December 2021
Competing interests
: Salim S. Abdool Karim is a member of the COVID advisory panel for emerging markets at Pfizer. The authors declare no other competing interests.